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ABSTRACT
Background: There is much interest in promoting healthy heart awareness among women.
However, little is known about the reasons behind the lower rates of heart disease among
women compared with men, and why this risk difference diminishes with age. Previous com-
parative studies have generally had insufficient numbers of women to quantify such differ-
ences reliably.
Methods: We carried out an individual participant data meta-analysis of 39 cohort studies
(32 from Asian countries and 7 from Australia and New Zealand). Cox models were used to
estimate hazard ratios (HR) for coronary death, comparing men to women. Further adjust-
ments were made for several proven coronary risk factors to quantify their contributions to
the sex differential. Sex interactions were tested for the same risk factors.
Results: During 4 million person-years of follow-up, there were 1989 (926 female) deaths
from coronary heart disease (CHD). The age-adjusted and study-adjusted male/female HR
(95% confidence interval [95% CI]) was 2.05 (1.89-2.22). At baseline, 54% of men vs. 7% of wo-
men were current smokers; hence, adjustment for smoking explained the largest component
(20%) of this HR. A significant sex interaction was observed between systolic blood pressure
(SBP) and CHD mortality such that a 10 mm Hg increase was associated with a 15% greater
increase in the relative risk (RR) of coronary death in women compared with men (p  0.002).
Conclusions: Only a small amount of the sex differential in coronary death could be ex-
plained by differences in the prevalence of classic risk factors. Alternative explanations are
required to explain the age-related attenuation of the sex difference in CHD risk.
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INTRODUCTION
ASUBSTANTIAL BODY OF EVIDENCE supports thehypothesis that within industrialized coun-
tries, men have a 3–5-fold greater risk of coronary
heart disease (CHD) mortality than women1–3
and that this risk difference diminishes over time,
to become only a 1–2-fold greater risk in the
eighth decade of life.3 Age-related differences be-
tween men and women in the levels of classic risk
factors, such as blood pressure, smoking, and
cholesterol level, may partly explain the sex dif-
ference. A lack of prospective data has previously
limited the ability to reliably quantify the contri-
butions of important risk factors to CHD mortal-
ity separately for men and women.
This project has received grants from the National Health and Medical Research Council of Australia and the Health
Research Council of New Zealand, the US National Institutes of Health, and an unrestricted educational grant from
Pfizer Inc.
The George Institute for International Health, University of Sydney, Sydney, NSW 2050, Australia.
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Interactions between sex and risk factors may ac-
count, in part, for some of the observed sex differ-
ence in CHD mortality rates. The most widely re-
ported sex interactions have been between smoking
and CHD4 and between diabetes and coronary
risk.5 In both instances, however, the sex interaction
appears to increase the risk among women rather
than men; Hence, such interactions, if real, would
act to attenuate rather than exacerbate the sex dif-
ferential in CHD risk. For example, a greater pro-
portionate effect of smoking in women has been
documented, with evidence that female smokers
have an approximately 50% higher relative risk
(RR) of dying from vascular disease than men.4 Sim-
ilarly, diabetes has been reported to eliminate the
female advantage, with diabetic women widely
considered to be at increased RR for CHD com-
pared with diabetic men.5 However, a recent meta-
analysis of prospective cohort studies refutes the
idea of a sex-diabetes interaction.6 Less is known
about whether sex interacts with other classic risk
factors, including blood pressure, lipids, and body
mass index (BMI), to modify CHD mortality risk in
men and women. If sex-risk factor interactions were
shown to exist, it would have substantial implica-
tions for treatment strategies and guidelines.
The Asia Pacific Cohort Studies Collaboration
(APCSC) comprises a large number of prospec-
tive cohort studies in the region and was estab-
lished primarily to provide reliable evidence
about the effects of a variety of modifiable risk
factors, including blood pressure, lipids, and di-
abetes, on the risks of cardiovascular diseases and
other common causes of death among popula-
tions in this region.7 The aims of this paper are
threefold: first, to quantify the contribution of in-
dividual risk factors to CHD mortality in men and
women; second, to quantify how much each of
the individual risk factors contributes to the ex-
cess risk difference in men; and third, to deter-
mine to what extent, if any, sex-risk factor inter-
actions influence the risk of CHD mortality
among men and women.
MATERIALS AND METHODS
Participating studies
APCSC is an overview conducted by the prin-
cipal investigators of prospective studies con-
ducted in the region. Details of the methods of
study identification and data collection are de-
scribed elsewhere.7 Cohort studies were eligible
for inclusion and were invited to participate if (1)
the study population was from the Asia-Pacific re-
gion, (2) date of birth, sex, and blood pressure of
each individual were recorded at baseline, and (3)
at least 5000 person-years of follow-up had been
completed. Studies that selected participants on
the basis of the absence or presence of any specific
disease or risk factor were excluded. Studies were
classified as Asian if their participants were re-
cruited from Mainland China, Hong Kong, Japan,
Korea, Singapore, Taiwan, or Thailand or ANZ if
their participants were recruited from Australia or
New Zealand. Each study reported deaths by un-
derlying cause; these were mostly ascertained
through data linkage. All outcomes were classified
according to the ninth revision of the International
Classification of Diseases (ICD-9). Each death was as-
cribed to its underlying cause as reported on the
death certificate. The primary end point consid-
ered in this paper is death from CHD (ICD 410-
414). All datasets were centrally checked for con-
sistency, and where necessary, further details were
sought from collaborating investigators.
Variables measured at baseline
In each study, age, sex, and blood pressure at
baseline were recorded. In most studies, blood
pressure was measured at rest in the seated posi-
tion using a standard mercury sphygmomano-
meter,8 and total cholesterol was generally mea-
sured from fasting serum.9 Baseline BMI, defined
as weight (kg) divided by height (m2),10 was
recorded. Smoking status was recorded as either
current smoker or nonsmoker of cigarettes. Dia-
betic status was determined on the basis of either
a reported history of diabetes at baseline or a fast-
ing venous blood sample11 according to the World
Health Organization (WHO) definition of diabetes
(i.e., fasting glucose 7.0 mmol/L or 2-hour post-
glucose load 11.1 mmol/L). More detailed infor-
mation about the measurement and recording of
these variables is given elsewhere.8–11
Statistical methods
Analyses used individual participant data and
were restricted to participants aged 20 years at
the time of the baseline survey. Two studies with
data only from men were excluded from all
analyses. Cox proportional hazard models were
used to analyze age-adjusted sex effects for the
relationships between known risk factors and fa-
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tal CHD. All analyses were adjusted for age as a
continuous variable and stratified by the cohort
of origin. This method allows background risk to
vary between studies but assumes that there are
equal relative effects of the risk factors through-
out. To determine if the associations of risk 
factors with fatal CHD are similar in men and 
women, we first examined across-study hetero-
geneity in the interactions between sex and risk
factors, after adjustment for other risk factors, by
conducting a random-effects meta-analysis of the
interactions and subsequently examining the ho-
mogeneity test statistic. If there was no evidence
of significant study heterogeneity, we proceeded
to test for interactions between sex and risk fac-
tors combining data from all studies, first in un-
adjusted analyses and then after adjusting for
each of the other risk factors separately and then
combined. All continuous exposure variables
were corrected for regression dilution.12
The percentage excess risk of CHD in men com-
pared with women that was due to differences in
risk factor levels was estimated by 100 ([HRU-
HRA]/[HRU  1])% where HRU and HRA are, re-
spectively, the hazard ratios for CHD comparing
men with women unadjusted (û) (except by age)
and after (Â) (further) adjustment for each risk fac-
tor alone and then for all risk factors combined.13
Because of the limited number of CHD events in
women, the high probability of finding false effects,
and previous findings from APCSC that there is no
regional heterogeneity in the associations between
risk factors and CHD,8–11 regional variations in sex
interactions were not examined.
RESULTS
Characteristics of study participants
The characteristics of studies within the
APCSC, after excluding those with no data on
women, and the mean values of risk factors at
baseline are shown in Table 1. During 4 million
person-years of follow-up, there were 2915 (926
female) deaths from CHD.
The amount of information available varied for
each risk factor examined (Table 2). For example,
data for blood pressure were available on all
577,417 individuals; for cigarette smoking,
543,280, and for diabetes, 361,710, aged between
20 and 107 years. Information on triglycerides
and high-density lipoprotein cholesterol (HDL-
C) was available from a much smaller number of
individuals. The mean values for the risk factors
shown in Table 2 were all highly significantly dif-
ferent (p  0.001) between men and women.
Overall, men were substantially more likely to
smoke than women (54% vs. 7%), to have dia-
betes (7.7% vs. 3.6%), to have higher levels of
triglycerides and systolic blood pressure (SBP),
and to have a higher total cholesterol/HDL-C 
ratio. Cholesterol levels were slightly higher in
women than in men but only in cohorts from
ANZ. The age and BMI difference between men
and women was negligible, although highly 
significant because of the large sample.
Sex-specific HRs for CHD
In the overall sample (n  577,417), the age-ad-
justed and study-adjusted HR for CHD in men
compared with women was 2.05 (95% CI 1.89-2.22).
In the much smaller subset of individuals for whom
data on all risk factors were available (n  58,606),
the overall age-adjusted and study-adjusted HR
was 2.42 (95% CI 1.94-3.01), which was attenuated
to 2.10 (95% CI, 1.68-2.45) after adjustment for all
risk factors. In age-adjusted analyses, cigarette
smoking, systolic blood pressure, BMI, diabetes, to-
tal cholesterol, triglycerides, and the total choles-
terol/HDL-C ratio were all significantly and posi-
tively associated with CHD mortality in both men
and women (Table 3).
Sex-risk factor interactions
The magnitudes of the age-adjusted and study-
adjusted associations between cigarette smoking,
total cholesterol, diabetes, triglycerides, and the
total cholesterol/HDL-C ratio with fatal CHD
were similar in men and women. This remained
true even after adjustment for other risk factors
(Table 3). Because of substantial differences in the
amount of information available for each of the
risk factors, the adjusted analyses were restricted
to the sample of individuals for whom data were
available on smoking, diabetes, BMI, total cho-
lesterol, and SBP (n  303,515). In the smaller
sample that had complete information on all 
risk factors including triglycerides and HDL-C
(n  58,606), the analyses were run to determine
whether a sex interaction exists between these
variables and fatal CHD.
We found no evidence of significant heterogene-
ity between the studies when we examined sex in-
teractions with each of the risk factors. Hence, the
following results are based on individual data from
ASIA PACIFIC COHORT STUDIES COLLABORATION822
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all studies combined. There was evidence of an in-
teraction between sex and both SBP and BMI in de-
termining the risk of fatal CHD. Exclusion of the
largest studies from these analyses (n  10,000 indi-
viduals) did not alter any of the tests for interaction.
In both age-adjusted and study-adjusted analy-
ses, SBP was more strongly associated with fatal
CHD in women than in men, such that a 10 mm
Hg increase in SBP was associated with a 35% in-
crease in risk in women compared with a 20% in-
crease in men. To ascertain whether this interaction
was a consequence of competing risk with stroke,
we subsequently tested for a sex interaction be-
tween SBP and fatal stroke and observed a signif-
icant interaction (p  0.001) such that an increase
in blood pressure was more strongly associated
with fatal stroke in men compared with women.
In unadjusted analyses, BMI was more strongly
associated with fatal CHD in men, such that a 2-
unit increase in BMI was associated with a 10%
increased risk in men compared with 3% in wo-
men. After adjustment for SBP, cholesterol, and
diabetes, the association between BMI and CHD
was attenuated so that BMI was no longer an in-
TABLE 1. APCSC STUDY CHARACTERISTICS
Median
Start year follow-up Female
Cohort name n (Range) (Years) % Men Women
Aito Town 1,717 1980–1983 15.2 56.7 9 7
Akabane 1,836 1985–1986 11.0 55.7 5 2
Anzhen 8,378 1991 4.3 55.1 35 30
Anzhen02 4,152 1992–1993 3.0 51.1 1 0
Australian Longitudinal 1,613 1992–1993 4.6 47.8 53 28
Study of Aging
Australian National Heart 9,277 1989–1990 8.3 50.9 58 19
Foundation
Beijing Steelworkers 8,957 1970 27.9 11.6 130 2
Busselton 7,881 1966–1981 20.5 51.9 392 296
Capital Iron and Steel 2,167 1992–1993 3.3 50.9 1 0
Company Hospital
Civil Service Workers 9,319 1990–1992 6.7 33.1 1 0
CVDFACTS 5,730 1988–1996 6.0 55.3 7 6
East Beijing 1,128 1977–1994 17.1 51.4 10 10
EGAT 3,497 1985 11.4 22.8 31 2
Fletcher Challenge 10,366 1992–1994 5.8 28.0 81 33
Guangzhou Occupational 167,377 1985–1998 7.3 21.7 152 16
Hisayama 1,616 1961 24.6 56.4 24 30
Hong Kong 3,006 1985–1991 2.5 57.5 36 50
Huashan 1,868 1990–1992 2.8 52.0 2 1
Kinmen 2,793 1993–1997 2.9 48.1 8 5
KMIC 183,600 1992 4.0 37.0 104 10
Kounan Town 1,226 1987–1995 6.4 55.4 2 0
Melbourne 41,286 1990–1994 8.5 58.9 242 81
Miyama 1,078 1988–1990 6.6 55.8 1 1
Newcastle 5,934 1983–1994 9.0 50.2 103 34
Ohasama 2,240 1992–1993 4.1 63.8 6 1
Perth 10,230 1978–1994 14.4 48.3 141 54
Saitama 3,624 1986–1990 11.0 62.2 14 10
Seven Cities Cohorts 10,811 1987 2.7 54.5 44 40
Shanghai Factory Workers 9,347 1972–1978 14.0 30.6 69 17
Shibata 2,350 1977 20.0 57.7 30 37
Shigaraki Town 3,758 1991–1997 4.4 59.4 3 0
Shirakawa 4,643 1974–1979 17.5 54.3 28 17
Singapore Heart 2,325 1982–1997 14.6 49.0 23 8
Singapore NHS92 3,305 1992 6.2 51.8 17 5
Six Cohorts 19,387 1982–1986 9.0 46.7 19 8
Tanno/Soubetsu 1,984 1977 16.4 53.1 18 6
Tianjin 9,335 1984 6.1 51.3 45 51
Xi’an 1,695 1976 19.7 33.7 26 9
Yunnan 6,581 1992 4.5 3.1 18 0
Total 577,417 1961–1998 6.7 36.5 1989 926
CHD deaths
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dependent predictor of CHD in women. This,
however, may be due to overadjustment of in-
termediary variables that lie on the causal path-
way between BMI and CHD (Table 3).
Figure 1 illustrates what proportion of the excess
risk of CHD mortality in men vs. women is ex-
plained by each the risk factors alone and by all the
risk factors combined. Cigarette smoking was the
single largest contributor, explaining approximately
20% of the excess CHD risk, chiefly as a result of the
vast difference in cigarette smoking rates (54% in
men vs. 7% in women). Sex differences in the total
cholesterol/HDL-C ratio, diabetes, and triglycerides
explained 6%, 3%, and 2% of the excess risk, re-
spectively. By comparison, adjustment for total cho-
lesterol increased the HR in men relative to women,
as a consequence of women having an overall
higher age-adjusted mean total cholesterol level
(Table 2). Similarly, adjustment for SBP also in-
creased the HR despite the fact that, overall, the age-
adjusted mean level of SBP was significantly greater
in men than in women (Table 2). Rather, the increase
in the HR, after adjusting for SBP, was due to its
much stronger interaction with CHD in women
compared with men. Simultaneous adjustment for
all risk factors reduced the excess risk of fatal CHD
in men compared with women by 23%.
DISCUSSION
Findings from this present study indicate that
the strength of association between classic CHD
risk factors, such as cigarette smoking, lipids and
diabetes, with fatal CHD is similar in magnitude
for both men and women. There was some evi-
dence to suggest that a sex-specific interaction ex-
isted between SBP and fatal CHD. In this study,
a 10 mm Hg increase in SBP was associated with
a 35% increased risk of fatal CHD among women
but with only a 20% increased risk among men.
However, this may be an artifact due to compet-
ing risks between stroke and CHD, as in this
study, an increase in blood pressure was more
strongly associated with the risk of incurring a fa-
tal stroke in men than in women.
Few published reports have commented on the
existence of sex differences in the associations be-
tween risk factors and CHD, with the exceptions
of diabetes and smoking, which have been the
subject of much debate in the literature. For ex-
ample, a meta-analysis of 10 prospective cohort
studies concluded that diabetes was more
strongly associated with CHD risk in women than
in men.14 However, a more recent meta-analysis
of 8 prospective studies that had adjusted for
other CHD risk factors concluded that the risk of
CHD was similar in both sexes, RR 2.3 (95% CI
1.9-2.8) in men vs. 2.9 (95% CI 2.2-3.8) in women.6
In this current study, the RR of fatal CHD asso-
ciated with diabetes tended to be greater in wo-
men than in men, although it was not signifi-
cantly so, possibly because of the small number
of fatal events among individuals with diabetes.
Findings from the current study suggest a
trend toward increased CHD risk in women who
smoked compared with male smokers, although
the test for interaction with sex was not signifi-
cant (p  0.29). Women who smoke have been re-
ported to have an approximate 50% increased risk
of incurring a cardiovascular event compared
with male smokers.2,4,15,16 In contrast, Jousilahti
et al.,3 in a large prospective Finnish cohort, re-
ported no sex interaction with smoking, as did
the Renfrew-Paisley prospective cohort in Scot-
tish adults.17 Two major limitations within the
APCSC are the lack of information on duration
of smoking and the limited information on the
number of cigarettes smoked by individuals. Fur-
ASIA PACIFIC COHORT STUDIES COLLABORATION824
TABLE 2. DISTRIBUTION OF VASCULAR RISK FACTORS
Men Women
Variablea n Mean 95% CI n Mean 95% CI
Age (years) 366,569 45.4 45.3–45.4 210,848 46.3 46.2–46.3
SBP (mm Hg) 366,569 124.1 124.1–124.2 210,848 121.3 121.2–121.3
BMI (kg/m2) 232,642 23.7 23.7–23.7 174,957 23.4 23.4–23.5
Total cholesterol (mmol/L) 214,446 5.06 5.06–5.07 158,721 5.10 5.10–5.11
Triglycerides (mmol/L) 49,203 1.58 1.57–1.59 44,505 1.30 1.29–1.31
Total cholesterol/HDL-C ratio 42,249 4.56 4.54–4.58 35,161 3.97 3.95–3.99
Diabetes (%) 208,634 7.7 7.5–7.7 153,076 3.6 3.5–3.7
Current smoking (%) 348,761 54.4 54.1–54.6 194,519 6.7 6.6–6.8
aAll variables adjusted for age.
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ther analyses, exploiting this limited information,
are reported elsewhere.18 In Asia, women have
only recently started to smoke.19 Hence, it is prob-
able that the RR of smoking in women obtained
from these current analyses is likely to underes-
timate the true effect. Our finding that there was
no sex differential associated with total choles-
terol and HDL-C accords with the few other stud-
ies that have commented on the relationship.2,3
In this current study, differences in levels of 
the classic cardiovascular risk factors explained
nearly a quarter of the excess CHD risk in men
compared with women. Of these, the sex difference
in the rate of cigarette smoking was the single most
important determinant of the excess CHD risk in
men. Differences in the levels of triglycerides, dia-
betes, and the total cholesterol/HDL-C ratio ex-
plained only a small proportion of the excess risk.
These findings contrast with those of Jousilahti et
al.,3 who reported that a sex difference in the total
cholesterol/HDL-C ratio and smoking explained
most of the risk factor-associated excess CHD risk.
However, Johnson20 concluded that differences in
smoking, total cholesterol, glucose intolerance, and
blood pressure did not account for the observed
sex difference in CHD risk within the Framingham
cohort.
Because of a lack of data on the use of prescribed
medication in study participants, we were unable
to evaluate the impact on CHD risk of any treat-
ment differences between men and women. Recent
evidence suggests that women are undertreated
compared with men with respect to cardiovascu-
lar risk factors. For example, in a recent study from
Norway, only 35% of women with diabetes or car-
diovascular disease were prescribed a statin com-
pared with 45% of men with similar medical his-
tories.21 Similar findings were reported from the
United Kingdom Prospective Diabetes Study,22
where women with diabetes were significantly less
likely to use aspirin compared with men. The con-
sequence of any treatment bias that favors men
would be to underestimate the contribution of clas-
sic risk factors to the sex differential.
A further limitation of APCSC is the lack of data
on new and emerging CHD risk factors. It is pos-
sible that differences in the levels of novel risk fac-
tors, such as fibrinogen, C-reactive protein, and
other inflammatory agents, may contribute to
some of the excess CHD risk observed in men. Sex
hormones may account for some of the sex differ-
ential in CHD risk. Prior to the menopause, at
around the age of 50 years, women are at consid-
erably lower risk of CHD compared with men, but
FIG. 1. Percentage of the age-adjusted CHD mortality HR for sex (men vs. women) explained by each of the risk
factors alone and by all risk factors combined. (0% explained corresponds to the HR for sex adjusted for age only.
All other adjustments also include age adjustment.)
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the sex difference in coronary risk gradually di-
minishes with increasing age,23 possibly as a con-
sequence of the postmenopausal decline in sex
hormones.24
CONCLUSIONS
In this large prospective database of studies
from the Asia-Pacific region, only a small amount
of the sex differential in CHD could be explained
by differences in the prevalence of classic risk fac-
tors. Future studies are required to elucidate the
mechanisms responsible for the attenuation of the
age-related sex difference in CHD risk.
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